News

Filter

Current filters:

Johnson & Johnson

1 to 9 of 2025 results

Janssen acquires UK virtual biopharma firm XO1

24-03-2015

US health care giant Johnson & Johnson subsidiary Janssen Pharmaceuticals, has acquired XO1 Limited,…

BiotechnologyCardio-vascularichorcumabJanssenJohnson & JohnsonMergers & AcquisitionsUKXO1 Limited

Kura Oncology gains rights to Janssen’s tipifarnib

14-03-2015

USA-based clinical-stage drug developer Kura Oncology has entered into an agreement with Janssen Pharmaceutica,…

FinancialJanssen PharmaceuticaJohnson & JohnsonKura OncologyLicensingMergers & AcquisitionsOncologyPharmaceuticaltipifarnib

Samsung Bioepis seeks EMA approval of Remicade biosimilar SB2

13-03-2015

South Korea-based Samsung Bioepis, a joint venture between Samsung and US biotech firm Biogen Idec, says…

Anti-Arthritics/RheumaticsBiogen IdecBiosimilarsEuropeGenericsJohnson & JohnsonRegulationRemicadeSamsung BioepisSB2

UK’s NICE recommends Stelara for psoriatic arthritis

UK’s NICE recommends Stelara for psoriatic arthritis

12-03-2015

Medicines cost watchdog for England, the National Institute for Health and Clinical Excellence (NICE),…

Anti-Arthritics/RheumaticsBiotechnologyInflammatory diseasesJanssenJohnson & JohnsonRegulationStelaraUK

2014 saw highest increase in US drug spend over past decade

2014 saw highest increase in US drug spend over past decade

10-03-2015

In 2014, the pharmacy landscape underwent a seismic change, and the budgetary impact to healthcare payers…

Anti-viralsFinancialGilead SciencesHarvoniHealthcareJohnson & JohnsonMarkets & MarketingOlysioPharmaceuticalSovaldiUSA

Biopharma sector subject to highest economic uncertainty of major European industries: report

Biopharma sector subject to highest economic uncertainty of major European industries: report

05-03-2015

The European biopharma sector faces the highest level of risk and economic uncertainty of six key European…

EuropeJanssenJohnson & JohnsonMarkets & MarketingPharmaceutical

AbbVie to acquire Pharmacyclics, aiming to create leading hematological oncology franchise

AbbVie to acquire Pharmacyclics, aiming to create leading hematological oncology franchise

05-03-2015

US drugmaker AbbVie revealed late yesterday that it has reached an agreement to acquire US biopharma…

AbbVieBiotechnologyHematologyImbruvicaJohnson & JohnsonMergers & AcquisitionsNovartisOncologyPharmacyclics

Hospira’s biosimilar Inflectra comparable to Remicade in IBD treatment

Hospira’s biosimilar Inflectra comparable to Remicade in IBD treatment

19-02-2015

Positive data have been presented today on the use of Hospira's Inflectra (infliximab), the world's first…

BiosimilarsBiotechnologyGastro-intestinalsHospiraInflectraJohnson & JohnsonMerck & CoRemicadeResearch

1 to 9 of 2025 results

Back to top